RIGEL ANNOUNCES ORAL PRESENTATION OF PHASE 1B DATA FOR R289 IN PATIENTS WITH LOWER-RISK MDS AT THE 68TH AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING AND EXPOSITION

Reuters · 1d ago

Please log in to view news